Recently HISUN obtained COS certificate for its API cyclophosphamide, thus allowing the company to enter the European market. The COS certificate was the eighth award to HISUN since January 2009 (two of which were new awards, while the remaining six were renewals), adding new impetus to HISUN's initiatives in the European pharmaceutical market. To-date HISUN has obtained 17 COS certificates of its products.
Related News
Photos
More>>
trade
- Neusoft Listed in The 2007 Global Services 100
- Dr.Liu Jiren Awarded Asia Innovator of the Year at the 6th CNBC Asia Business
- Neusoft CEO Attended the 2010 Summer Davos and Highlighted the New Challenges
- Neusoft CEO Dr. Liu Jiren Named Country Winner of Ernst and Young Entrepreneur
- Kaisa Group received 2010 Listed Real Estate Company of the Highest Investment
market
- Kaisa Group announces interim results for 2010
- Kaisa Group among TOP10 brands of South China real estate companies 6 years in a
- Kaisa Group earned PRC best employer title for 2010
- Campus recruitment for 2011 graduates started with Shenzhen University
- Kaisa Group named among Most Valuable PRC Listed Blue-chip Real Estate Companies
finance
- Kaisa Group ranks 5th among TOP 10 China-Affiliated HK-Listed Companies of
- Insigma being awarded the Grand Prize for Y2009 International Service Outsourcin
- Insigma Continues to Hold 2nd Place in China s Software Outsourcing Industry in
- Insigma presented at Gartner Outsourcing Summit
- CWHK University alliance key to Insigma s success